Niagen Bioscience Inc (NAGE)

$9.51 -0.09 (-0.94%)
Market Cap 748.08M
Revenue (ttm) 99.60M
Net Income (ttm) 8.55M
EPS (ttm) N/A
PE Ratio 72.69
Forward PE 74.61
Profit Margin 8.58%
Debt to Equity Ratio 0.00
Volume 558,756
Avg Vol 1,105,864
Day's Range N/A - N/A
Shares Out 79.75M
Stochastic %K 32%
Beta 2.21
Analysts Strong Sell
Price Target $15.55

Company Profile

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient...

Industry: Biotechnology
Sector: Healthcare
Phone: 310 388 6706
Address:
10900 Wilshire Blvd, Suite 600, Los Angeles, United States
wycliff
wycliff Sep. 11 at 2:57 AM
$NAGE
0 · Reply
wycliff
wycliff Sep. 10 at 1:44 AM
$NAGE https://nypost.com/2025/09/09/health/buzzy-treatment-boosts-energy-better-sleep-and-recovery/
0 · Reply
ryan125
ryan125 Sep. 9 at 7:58 PM
$NAGE https://nypost.com/2025/09/09/health/buzzy-treatment-boosts-energy-better-sleep-and-recovery/
1 · Reply
wycliff
wycliff Sep. 9 at 7:20 PM
$NAGE https://www.eatingwell.com/best-supplements-to-take-for-more-energy-11778578
0 · Reply
stupidusername
stupidusername Sep. 6 at 2:39 PM
$NAGE yahoo is unusable as a board. I can’t post or even like a comment. If anyone over there makes a comment please encourage more participation here. Would be great to be able to engage with that group.
1 · Reply
wycliff
wycliff Sep. 6 at 12:01 PM
$NAGE https://longevity.technology/news/niagen-bioscience-secures-exclusive-rights-for-parkinsons-therapy/
0 · Reply
wycliff
wycliff Sep. 5 at 4:52 PM
$NAGE https://x.com/niagenplus/status/1964001631667671425?s=42
1 · Reply
Jimgym
Jimgym Sep. 3 at 6:04 PM
$NAGE Example of an infringer and shady company On the same page this company claims their NR is “made in US”, while also saying it’s made by effepharm (which only manufacturers in China) Niagen is the only reputable source https://shop.partiqlar.com/product/pure-nicotinamide-riboside-nr/
1 · Reply
wycliff
wycliff Sep. 3 at 3:44 PM
$NAGE https://www.linkedin.com/posts/niagenbioscience_scientificadvisoryboard-agingresearch-dnarepair-activity-7369019550119460867-zqML?utm_medium=ios_app&rcm=ACoAAAUGerIBOiyuZoO-6U9HRKRzZ48AD8YnjZA&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply
okeydokey_artichokey
okeydokey_artichokey Sep. 3 at 3:18 PM
$NAGE The drum I will beat to death - the overriding driver for NR must be cost reduction. The NAD space over time will be commodified (I'm thinking like creatine). The NMN ban wether upheld or not will be/is already trivialized by online street vendors, "pharmacies" and all manner of grey-zone health care. The $1K IVs are disgusting. My fevered speculation is that in a reasonable future, at some level, this company may be in competition with the GLP-1 pricepoint. In my city Med Spas are selling sub-clinical GLP_1 doses for performance and and health on the cheap. I welcome your indifference, and mockery.
1 · Reply
Latest News on NAGE
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook

Aug 6, 2025, 4:02 PM EDT - 5 weeks ago

Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook

Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth Conference

Aug 4, 2025, 8:32 AM EDT - 5 weeks ago

Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth Conference

Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Jul 23, 2025, 8:34 AM EDT - 7 weeks ago

Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Niagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New York

Jul 14, 2025, 8:32 AM EDT - 2 months ago

Niagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New York

Niagen Bioscience Secures Exclusive License to Develop and Commercialize its NAD+ Precursor, Patented Nicotinamide Riboside (Niagen®), as a Potential Parkinson's Disease Therapy in Agreement with Haukeland University Hospital in Bergen, Norway

Jul 8, 2025, 8:32 AM EDT - 2 months ago

Niagen Bioscience Secures Exclusive License to Develop and Commercialize its NAD+ Precursor, Patented Nicotinamide Riboside (Niagen®), as a Potential Parkinson's Disease Therapy in Agreement with Haukeland University Hospital in Bergen, Norway

Niagen Biosciences: Anti-Aging Market Leader And Prime Beneficiary Of Long-Term Demographic Trends

Jun 24, 2025, 4:27 PM EDT - 2 months ago

Niagen Biosciences: Anti-Aging Market Leader And Prime Beneficiary Of Long-Term Demographic Trends

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

Jun 20, 2025, 8:32 AM EDT - 2 months ago

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

Niagen Bioscience to Participate in the BIO 2025 International Convention

Jun 11, 2025, 8:31 AM EDT - 3 months ago

Niagen Bioscience to Participate in the BIO 2025 International Convention

Niagen Bioscience: High Conviction, High Expectations

Jun 11, 2025, 6:48 AM EDT - 3 months ago

Niagen Bioscience: High Conviction, High Expectations

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Jun 9, 2025, 8:32 AM EDT - 3 months ago

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Niagen Bioscience to Present at Oppenheimer's 25th Annual Consumer Growth and E-Commerce Conference

Jun 4, 2025, 8:32 AM EDT - 3 months ago

Niagen Bioscience to Present at Oppenheimer's 25th Annual Consumer Growth and E-Commerce Conference

Niagen Bioscience, Inc. (NAGE) Q1 202 Earnings Call Transcript

May 10, 2025, 1:40 PM EDT - 4 months ago

Niagen Bioscience, Inc. (NAGE) Q1 202 Earnings Call Transcript

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

May 7, 2025, 4:02 PM EDT - 4 months ago

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

May 5, 2025, 8:32 AM EDT - 4 months ago

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Apr 29, 2025, 8:32 AM EDT - 4 months ago

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Apr 28, 2025, 8:34 AM EDT - 4 months ago

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Apr 7, 2025, 10:32 PM EDT - 5 months ago

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments

Apr 7, 2025, 8:32 AM EDT - 5 months ago

Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments

Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms

Mar 20, 2025, 8:34 AM EDT - 6 months ago

Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science

Mar 19, 2025, 8:34 AM EDT - 6 months ago

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science

ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025

Mar 13, 2025, 8:34 AM EDT - 6 months ago

ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025

ChromaDex to Present at the 37th Annual Roth Conference

Mar 11, 2025, 4:04 PM EDT - 6 months ago

ChromaDex to Present at the 37th Annual Roth Conference

ChromaDex Capitalizes On Longevity Boom But Valuation Remains High

Mar 6, 2025, 10:30 AM EST - 6 months ago

ChromaDex Capitalizes On Longevity Boom But Valuation Remains High

ChromaDex Corporation (CDXC) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 8:53 PM EST - 6 months ago

ChromaDex Corporation (CDXC) Q4 2024 Earnings Call Transcript

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results

Mar 4, 2025, 4:02 PM EST - 6 months ago

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results

ChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025

Feb 25, 2025, 4:07 PM EST - 7 months ago

ChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025

ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 6, 2025, 8:32 AM EST - 8 months ago

ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

Dec 3, 2024, 8:34 AM EST - 10 months ago

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

ChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement

Nov 14, 2024, 8:32 AM EST - 10 months ago

ChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement

ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide

Nov 7, 2024, 8:32 AM EST - 11 months ago

ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide

ChromaDex Corporation (CDXC) Q3 2024 Earnings Call Transcript

Nov 1, 2024, 2:48 PM EDT - 11 months ago

ChromaDex Corporation (CDXC) Q3 2024 Earnings Call Transcript

ChromaDex Corporation Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 4:04 PM EDT - 11 months ago

ChromaDex Corporation Reports Third Quarter 2024 Financial Results

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

Oct 28, 2024, 8:32 AM EDT - 11 months ago

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

ChromaDex to Participate in the 17th Annual LD Micro Main Event

Oct 23, 2024, 8:34 AM EDT - 11 months ago

ChromaDex to Participate in the 17th Annual LD Micro Main Event

Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)

Oct 15, 2024, 8:32 AM EDT - 11 months ago

Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)

ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference

Sep 26, 2024, 4:12 PM EDT - 1 year ago

ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference

ChromaDex Appoints Ozan Pamir as Chief Financial Officer

Sep 20, 2024, 8:32 AM EDT - 1 year ago

ChromaDex Appoints Ozan Pamir as Chief Financial Officer

ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics

Sep 10, 2024, 8:32 AM EDT - 1 year ago

ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics

ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions

Sep 9, 2024, 8:34 AM EDT - 1 year ago

ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions

ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024

Aug 23, 2024, 8:34 AM EDT - 1 year ago

ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024

ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+

Aug 19, 2024, 8:32 AM EDT - 1 year ago

ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+

ChromaDex Corporation Reports Second Quarter 2024 Financial Results

Aug 7, 2024, 4:04 PM EDT - 1 year ago

ChromaDex Corporation Reports Second Quarter 2024 Financial Results

ChromaDex to Present at Canaccord Genuity's 44th Annual Growth Conference

Aug 5, 2024, 8:32 AM EDT - 1 year ago

ChromaDex to Present at Canaccord Genuity's 44th Annual Growth Conference

ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

Jul 24, 2024, 8:34 AM EDT - 1 year ago

ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)

Jul 23, 2024, 8:32 AM EDT - 1 year ago

ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)

ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel

Jul 22, 2024, 8:34 AM EDT - 1 year ago

ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel

ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August

Jul 16, 2024, 8:34 AM EDT - 1 year ago

ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August

ChromaDex to Join Russell 2000® Index

Jul 1, 2024, 8:32 AM EDT - 1 year ago

ChromaDex to Join Russell 2000® Index

ChromaDex: Looking To Take The Big Step Into Pharma

Jun 26, 2024, 12:20 PM EDT - 1 year ago

ChromaDex: Looking To Take The Big Step Into Pharma

Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)

Jun 24, 2024, 8:32 AM EDT - 1 year ago

Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)

wycliff
wycliff Sep. 11 at 2:57 AM
$NAGE
0 · Reply
wycliff
wycliff Sep. 10 at 1:44 AM
$NAGE https://nypost.com/2025/09/09/health/buzzy-treatment-boosts-energy-better-sleep-and-recovery/
0 · Reply
ryan125
ryan125 Sep. 9 at 7:58 PM
$NAGE https://nypost.com/2025/09/09/health/buzzy-treatment-boosts-energy-better-sleep-and-recovery/
1 · Reply
wycliff
wycliff Sep. 9 at 7:20 PM
$NAGE https://www.eatingwell.com/best-supplements-to-take-for-more-energy-11778578
0 · Reply
stupidusername
stupidusername Sep. 6 at 2:39 PM
$NAGE yahoo is unusable as a board. I can’t post or even like a comment. If anyone over there makes a comment please encourage more participation here. Would be great to be able to engage with that group.
1 · Reply
wycliff
wycliff Sep. 6 at 12:01 PM
$NAGE https://longevity.technology/news/niagen-bioscience-secures-exclusive-rights-for-parkinsons-therapy/
0 · Reply
wycliff
wycliff Sep. 5 at 4:52 PM
$NAGE https://x.com/niagenplus/status/1964001631667671425?s=42
1 · Reply
Jimgym
Jimgym Sep. 3 at 6:04 PM
$NAGE Example of an infringer and shady company On the same page this company claims their NR is “made in US”, while also saying it’s made by effepharm (which only manufacturers in China) Niagen is the only reputable source https://shop.partiqlar.com/product/pure-nicotinamide-riboside-nr/
1 · Reply
wycliff
wycliff Sep. 3 at 3:44 PM
$NAGE https://www.linkedin.com/posts/niagenbioscience_scientificadvisoryboard-agingresearch-dnarepair-activity-7369019550119460867-zqML?utm_medium=ios_app&rcm=ACoAAAUGerIBOiyuZoO-6U9HRKRzZ48AD8YnjZA&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply
okeydokey_artichokey
okeydokey_artichokey Sep. 3 at 3:18 PM
$NAGE The drum I will beat to death - the overriding driver for NR must be cost reduction. The NAD space over time will be commodified (I'm thinking like creatine). The NMN ban wether upheld or not will be/is already trivialized by online street vendors, "pharmacies" and all manner of grey-zone health care. The $1K IVs are disgusting. My fevered speculation is that in a reasonable future, at some level, this company may be in competition with the GLP-1 pricepoint. In my city Med Spas are selling sub-clinical GLP_1 doses for performance and and health on the cheap. I welcome your indifference, and mockery.
1 · Reply
wycliff
wycliff Sep. 3 at 2:27 AM
$NAGE https://www.fool.com/earnings/call-transcripts/2025/08/06/niagen-nage-q2-2025-earnings-call-transcript/?source=mitrade&utm_source=mitrade&utm_medium=feed&utm_campaign=article&referring_guid=0d29401e-abc5-4741-ac55-62737460a7f7
0 · Reply
wycliff
wycliff Sep. 2 at 8:28 PM
$NAGE https://drive.google.com/file/d/151bapmkRJh0At4rc5UXxtI8vBornsFMw/view
0 · Reply
wycliff
wycliff Sep. 2 at 8:13 PM
$NAGE https://finance.yahoo.com/news/niagen-bioscience-inc-nasdaq-nage-180637530.html
0 · Reply
Jimgym
Jimgym Sep. 2 at 1:50 AM
$NAGE nestle ceo who hasn’t been a huge fan of NHS division, is out.
1 · Reply
okeydokey_artichokey
okeydokey_artichokey Sep. 1 at 2:32 PM
$NAGE Just a review piece(08/29), nothing of which most on this board are not aware. https://www.cell.com/trends/cell-biology/fulltext/S0962-8924(25)00172-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0962892425001722%3Fshowall%3Dtrue
0 · Reply
okeydokey_artichokey
okeydokey_artichokey Aug. 31 at 8:52 PM
$NAGE I've emailed comp twice on injectable kinetics data. No response. I'd also like to water stability data for this product. is it buffered??
1 · Reply
Jimgym
Jimgym Aug. 30 at 6:58 PM
$NAGE https://wellsrx.com/product/niagen-plus/
0 · Reply
wycliff
wycliff Aug. 30 at 9:50 AM
$NAGE https://www.linkedin.com/posts/wellspharmacynetwork_experience-the-convenience-of-pharmaceutical-grade-activity-7367309330833895425-EEkA?utm_medium=ios_app&rcm=ACoAAAUGerIBOiyuZoO-6U9HRKRzZ48AD8YnjZA&utm_source=screenshot_social_share&utm_campaign=copy_link
0 · Reply
wycliff
wycliff Aug. 29 at 7:52 PM
$NAGE https://x.com/niagenplus/status/1961466752648241619?s=46&t=__Y6Jc4u9xx6Yl0Ih9I5Fw
0 · Reply
Doozio
Doozio Aug. 29 at 6:23 PM
$NAGE 3wt bahhhhtom of da base. 🐑 in the HOOD shud be in cash for 🐑 senality. September is bahhhhhd they say! 🐒🍌🧠⏰♾️
0 · Reply
Jimgym
Jimgym Aug. 29 at 4:36 PM
$NAGE https://www.sciencedirect.com/science/article/abs/pii/S1043466625001620
1 · Reply
MattManzanita
MattManzanita Aug. 29 at 4:30 PM
$NAGE - I am writing this here to try to get Niagen Bio's attention. Has Niagen Bio tried to get Niagen on cruise ships, including Niagen Plus? There are between 400,000 and 500,000, mostly older people with money, on cruise ships at any one time. They have time to learn about new things. Cruise ships have spas and even medical personnel. Cruise ship have stores. They can hold seminars to promote things. They can re-run seminars on in cabin TV. They put out daily news letters with promotions. Niagen Bio can give cruise ships special pricing since once on land the new customers have to buy from traditional sources. Many cruise ship customers are foreign, so they can reach new markets. I read that people are generally drinking less alcohol, especially those under age 40. Cruise ship will need new sources of onboard sales.
0 · Reply